Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status

This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (L...

Full description

Saved in:
Bibliographic Details
Published inJournal of thrombosis and thrombolysis Vol. 37; no. 4; pp. 455 - 463
Main Authors Zhang, Xuguang, McGeoch, Susan C., Johnstone, Alexandra M., Holtrop, Grietje, Sneddon, Alan A., MacRury, Sandra M., Megson, Ian L., Pearson, Donald W. M., Abraham, Prakash, De Roos, Baukje, Lobley, Gerald E., O’Kennedy, Niamh
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.05.2014
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0929-5305
1573-742X
1573-742X
DOI10.1007/s11239-013-1000-2

Cover

Loading…
Abstract This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP ( P  = 0.003), and PMP that were fibrinogen-positive ( P  = 0.04), tissue factor-positive ( P  < 0.001), P-selectin-positive ( P  = 0.03). Type 2 diabetes did not alter either total or activated LMP or MMP. Obesity per se did not impact on any MP measurement. Elevated concentrations of plasma PMP occurred in subjects with type 2 diabetes, whether they were obese or non-obese. In contrast, obesity in the absence of type 2 diabetes had no effect. The increased concentrations of specific marker-positive PMP in the subjects with diabetes might reflect potential pathways by which PMP may contribute to the pathogenesis of atherosclerosis and type 2 diabetes.
AbstractList This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP (P = 0.003), and PMP that were fibrinogen-positive (P = 0.04), tissue factor-positive (P < 0.001), P-selectin-positive (P = 0.03). Type 2 diabetes did not alter either total or activated LMP or MMP. Obesity per se did not impact on any MP measurement. Elevated concentrations of plasma PMP occurred in subjects with type 2 diabetes, whether they were obese or non-obese. In contrast, obesity in the absence of type 2 diabetes had no effect. The increased concentrations of specific marker-positive PMP in the subjects with diabetes might reflect potential pathways by which PMP may contribute to the pathogenesis of atherosclerosis and type 2 diabetes.
This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP ( P  = 0.003), and PMP that were fibrinogen-positive ( P  = 0.04), tissue factor-positive ( P  < 0.001), P-selectin-positive ( P  = 0.03). Type 2 diabetes did not alter either total or activated LMP or MMP. Obesity per se did not impact on any MP measurement. Elevated concentrations of plasma PMP occurred in subjects with type 2 diabetes, whether they were obese or non-obese. In contrast, obesity in the absence of type 2 diabetes had no effect. The increased concentrations of specific marker-positive PMP in the subjects with diabetes might reflect potential pathways by which PMP may contribute to the pathogenesis of atherosclerosis and type 2 diabetes.
This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP (P = 0.003), and PMP that were fibrinogen-positive (P = 0.04), tissue factor-positive (P < 0.001), P-selectin-positive (P = 0.03). Type 2 diabetes did not alter either total or activated LMP or MMP. Obesity per se did not impact on any MP measurement. Elevated concentrations of plasma PMP occurred in subjects with type 2 diabetes, whether they were obese or non-obese. In contrast, obesity in the absence of type 2 diabetes had no effect. The increased concentrations of specific marker-positive PMP in the subjects with diabetes might reflect potential pathways by which PMP may contribute to the pathogenesis of atherosclerosis and type 2 diabetes.This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP (P = 0.003), and PMP that were fibrinogen-positive (P = 0.04), tissue factor-positive (P < 0.001), P-selectin-positive (P = 0.03). Type 2 diabetes did not alter either total or activated LMP or MMP. Obesity per se did not impact on any MP measurement. Elevated concentrations of plasma PMP occurred in subjects with type 2 diabetes, whether they were obese or non-obese. In contrast, obesity in the absence of type 2 diabetes had no effect. The increased concentrations of specific marker-positive PMP in the subjects with diabetes might reflect potential pathways by which PMP may contribute to the pathogenesis of atherosclerosis and type 2 diabetes.
This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the pathways by which these are associated with either condition. The concentrations of circulating MP derived from platelets (PMP), leukocytes (LMP) and monocytes (MMP), together with their specific activation markers, were compared in 30 subjects who were characterised across 4 cohorts as obese or type 2 diabetes. The subjects with type 2 diabetes had elevated concentrations of total PMP (P = 0.003), and PMP that were fibrinogen-positive (P = 0.04), tissue factor-positive (P < 0.001), P-selectin-positive (P = 0.03). Type 2 diabetes did not alter either total or activated LMP or MMP. Obesity per se did not impact on any MP measurement. Elevated concentrations of plasma PMP occurred in subjects with type 2 diabetes, whether they were obese or non-obese. In contrast, obesity in the absence of type 2 diabetes had no effect. The increased concentrations of specific marker-positive PMP in the subjects with diabetes might reflect potential pathways by which PMP may contribute to the pathogenesis of atherosclerosis and type 2 diabetes.[PUBLICATION ABSTRACT]
Author Megson, Ian L.
MacRury, Sandra M.
Johnstone, Alexandra M.
Holtrop, Grietje
McGeoch, Susan C.
Abraham, Prakash
Zhang, Xuguang
Sneddon, Alan A.
De Roos, Baukje
O’Kennedy, Niamh
Pearson, Donald W. M.
Lobley, Gerald E.
Author_xml – sequence: 1
  givenname: Xuguang
  surname: Zhang
  fullname: Zhang, Xuguang
  organization: Rowett Institute of Nutrition and Health, University of Aberdeen
– sequence: 2
  givenname: Susan C.
  surname: McGeoch
  fullname: McGeoch, Susan C.
  organization: Department of Diabetes, Aberdeen Royal Infirmary
– sequence: 3
  givenname: Alexandra M.
  surname: Johnstone
  fullname: Johnstone, Alexandra M.
  organization: Rowett Institute of Nutrition and Health, University of Aberdeen
– sequence: 4
  givenname: Grietje
  surname: Holtrop
  fullname: Holtrop, Grietje
  organization: Biomathematics and Statistics Scotland, Rowett Institute of Nutrition & Health
– sequence: 5
  givenname: Alan A.
  surname: Sneddon
  fullname: Sneddon, Alan A.
  organization: Rowett Institute of Nutrition and Health, University of Aberdeen
– sequence: 6
  givenname: Sandra M.
  surname: MacRury
  fullname: MacRury, Sandra M.
  organization: Department of Diabetes and Cardiovascular Science, University of the Highlands and Islands
– sequence: 7
  givenname: Ian L.
  surname: Megson
  fullname: Megson, Ian L.
  organization: Department of Diabetes and Cardiovascular Science, University of the Highlands and Islands
– sequence: 8
  givenname: Donald W. M.
  surname: Pearson
  fullname: Pearson, Donald W. M.
  organization: Department of Diabetes, Aberdeen Royal Infirmary
– sequence: 9
  givenname: Prakash
  surname: Abraham
  fullname: Abraham, Prakash
  organization: Department of Diabetes, Aberdeen Royal Infirmary
– sequence: 10
  givenname: Baukje
  surname: De Roos
  fullname: De Roos, Baukje
  organization: Rowett Institute of Nutrition and Health, University of Aberdeen
– sequence: 11
  givenname: Gerald E.
  surname: Lobley
  fullname: Lobley, Gerald E.
  organization: Rowett Institute of Nutrition and Health, University of Aberdeen
– sequence: 12
  givenname: Niamh
  surname: O’Kennedy
  fullname: O’Kennedy, Niamh
  email: niamh.okennedy@provexis.com
  organization: Provexis Plc, c/o University of Aberdeen, Rowett Institute of Nutrition & Health
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24097206$$D View this record in MEDLINE/PubMed
BookMark eNp9kc9qFTEUxoNU7G31AdxIwE0XHc3fycxSilWhUBcK7kKSOaO5zCRjkrG9L-OzmuttQQp1k-SQ33f4zndO0FGIARB6SckbSoh6myllvG8I5U2tScOeoA2VijdKsG9HaEN61jeSE3mMTnLeVqTvCXuGjpkgvWKk3aDfnydTYILSDJD8Lxjw7F2Ki0nFuwmwi2so2IQB5zWNxgGe4wRurV9wuyTI2ceABz-OkLCFcgMQKmq34ErGN778-CveP-JacNktgFnlTWUhn2MfBligHqFMOxxHHC1kX3Y4F1PW_Bw9Hc2U4cXdfYq-Xr7_cvGxubr-8Oni3VXjuGLVu2iNkdJ1lFpL2lZZyamlg6JESQeCm06aTghrlTSC95ZT4UTXOSZtN0jCT9HZoe-S4s8VctGzzw6myQSIa9ZU0pb3HW-7ir5-gG7jmkJ1t6ekkH1LVKVe3VGrnWHQS_KzSTt9n3wF1AGoaeecYNTO15FrmiUZP2lK9H7H-rBjXXe8r4lmVUkfKO-b_0_DDppc2fAd0j-mHxX9AVq7uqE
CitedBy_id crossref_primary_10_1016_j_mam_2018_12_001
crossref_primary_10_3390_nu13072184
crossref_primary_10_1002_pmic_201800248
crossref_primary_10_1016_j_rec_2015_12_033
crossref_primary_10_1080_17843286_2015_1110894
crossref_primary_10_3390_cells10123331
crossref_primary_10_33667_2078_5631_2019_1_1_376__53_58
crossref_primary_10_2174_1573399820666230829094724
crossref_primary_10_1093_biolre_ioab060
crossref_primary_10_1089_met_2017_0089
crossref_primary_10_1155_2021_5545416
crossref_primary_10_3389_fphar_2023_1166123
crossref_primary_10_1016_j_recesp_2015_12_034
crossref_primary_10_1210_endocr_bqad099
crossref_primary_10_1007_s11906_016_0678_x
crossref_primary_10_1016_j_cca_2017_12_048
crossref_primary_10_17816_KMJ2022_641
crossref_primary_10_3343_alm_2018_38_3_274
crossref_primary_10_3390_biomedicines12061322
crossref_primary_10_32345_2664_4738_1_2_2019_12
crossref_primary_10_1080_14767058_2023_2183767
crossref_primary_10_3390_biomedicines8100409
crossref_primary_10_1210_me_2015_1206
crossref_primary_10_3390_ijms21093222
crossref_primary_10_1155_2019_6475187
crossref_primary_10_3390_jcm10020327
crossref_primary_10_1160_TH16_11_0837
crossref_primary_10_3389_fcvm_2021_632131
crossref_primary_10_1089_ars_2017_7289
crossref_primary_10_3390_ijms21010146
crossref_primary_10_3390_nu16213717
crossref_primary_10_3390_ijms22084108
crossref_primary_10_1186_s12933_018_0763_3
crossref_primary_10_1160_TH14_02_0156
crossref_primary_10_1186_s12933_018_0783_z
crossref_primary_10_1177_1076029619845056
crossref_primary_10_1016_j_mam_2017_11_010
crossref_primary_10_1210_clinem_dgad473
crossref_primary_10_1016_j_ejcb_2023_151311
crossref_primary_10_1007_s10620_024_08640_1
crossref_primary_10_3390_ijms20246345
crossref_primary_10_51847_eilLCorjfQ
crossref_primary_10_1017_S0007114515001117
crossref_primary_10_1016_j_jss_2015_08_025
crossref_primary_10_1016_j_mam_2017_11_009
crossref_primary_10_1160_TH16_03_0176
crossref_primary_10_1016_j_thromres_2014_11_011
crossref_primary_10_1371_journal_pone_0102310
crossref_primary_10_1681_ASN_2018040368
crossref_primary_10_1089_ars_2019_7922
crossref_primary_10_1186_s12933_021_01267_w
crossref_primary_10_1161_JAHA_122_027071
crossref_primary_10_1055_s_0041_1740150
crossref_primary_10_3389_fphar_2016_00293
crossref_primary_10_1038_aps_2017_77
crossref_primary_10_1080_09537104_2016_1254174
Cites_doi 10.2741/1466
10.1017/S0007114511000092
10.1161/01.ATV.0000249639.36915.04
10.1016/j.thromres.2010.01.035
10.1016/j.amjcard.2006.01.054
10.1111/j.1538-7836.2004.00941.x
10.1146/annurev-immunol-031210-101322
10.1111/j.1464-5491.2005.01707.x
10.1080/09537100802054107
10.1038/sj.ijo.0801938
10.3324/haematol.2013.083808
10.3324/haematol.2012.066167
10.1016/j.thromres.2010.07.006
10.1177/1076029611405032
10.1373/clinchem.2005.057414
10.1097/MCO.0b013e32832c6db7
10.1016/S0008-6363(03)00367-5
10.1080/09537100701817232
10.1080/09537100600864285
10.1161/01.CIR.97.21.2099
10.1093/eurheartj/ehi746
10.1080/00207230500120401
10.1002/ana.21681
10.1161/01.CIR.102.14.1634
10.1038/jhh.2008.138
10.1378/chest.124.3_suppl.4S
10.1532/IJH97.03167
10.1016/j.ehj.2003.08.021
10.1161/01.CIR.101.8.841
10.2337/diabetes.51.9.2840
10.1172/JCI27196
10.1016/j.thromres.2005.12.013
10.1161/01.HYP.0000231507.00962.b5
10.1016/j.thromres.2009.10.006
10.1111/j.1538-7836.2005.01780.x
10.1681/ASN.2005050535
10.1007/s00125-001-0772-7
10.1016/S1262-3636(07)70251-3
10.1161/01.CIR.0000036596.59665.C6
10.1016/j.vph.2011.03.005
10.1016/S0049-3848(02)00334-1
10.1007/s10544-012-9642-y
10.1182/blood.V94.11.3791
10.1182/blood.V93.3.876
10.1160/TH07-10-0602
ContentType Journal Article
Copyright Springer Science+Business Media New York 2013
Springer Science+Business Media New York 2014
Copyright_xml – notice: Springer Science+Business Media New York 2013
– notice: Springer Science+Business Media New York 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s11239-013-1000-2
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-742X
EndPage 463
ExternalDocumentID 3273539221
24097206
10_1007_s11239_013_1000_2
Genre Multicenter Study
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Chief Scientist Office
  grantid: CZB/4/644
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
1SB
2.D
203
28-
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACSNA
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
IMOTQ
IWAJR
IXC
IXD
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAK
LLZTM
M1P
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z82
Z87
Z8O
Z8V
Z91
ZMTXR
ZOVNA
~A9
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
7TK
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c372t-d46aa55c811bb0667b531b1d71075ce43a85a844bb75a439b314c488c25b8d503
IEDL.DBID U2A
ISSN 0929-5305
1573-742X
IngestDate Fri Jul 11 01:29:40 EDT 2025
Sat Aug 16 03:12:15 EDT 2025
Mon Jul 21 05:54:38 EDT 2025
Thu Apr 24 23:01:55 EDT 2025
Tue Jul 01 02:26:37 EDT 2025
Fri Feb 21 02:36:56 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Obesity
Circulating cell-derived microparticles
Type 2 diabetes mellitus
Blood platelets
Cardiovascular diseases
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-d46aa55c811bb0667b531b1d71075ce43a85a844bb75a439b314c488c25b8d503
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
PMID 24097206
PQID 1515459607
PQPubID 44413
PageCount 9
ParticipantIDs proquest_miscellaneous_1516398368
proquest_journals_1515459607
pubmed_primary_24097206
crossref_citationtrail_10_1007_s11239_013_1000_2
crossref_primary_10_1007_s11239_013_1000_2
springer_journals_10_1007_s11239_013_1000_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-05-01
PublicationDateYYYYMMDD 2014-05-01
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: Netherlands
– name: Dordrecht
PublicationSubtitle A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science
PublicationTitle Journal of thrombosis and thrombolysis
PublicationTitleAbbrev J Thromb Thrombolysis
PublicationTitleAlternate J Thromb Thrombolysis
PublicationYear 2014
Publisher Springer US
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer Nature B.V
References Evangelista, Manarini, Sideri, Rotondo (CR38) 1999; 93
Diamant, Nieuwland, Pablo, Sturk (CR34) 2002; 106
Arteaga, Chirinos, Soriano, Jy (CR44) 2006; 98
Garcia Rodriguez, Eikenboom, Tesselaar, Huisman (CR1) 2010; 126
Jung, Chu, Lee, Park (CR17) 2009; 66
Wildman (CR27) 2009; 12
Omoto, Nomura, Shouzu, Nishikawa (CR48) 2002; 45
CR32
Sabatier, Darmon, Hugel, Combes (CR13) 2002; 51
Blann, Nadar, Lip (CR39) 2003; 24
Morel, Ohlmann, Morel, Jesel (CR7) 2005; 98
Lacroix, Plawinski, Robert, Doeuvre (CR50) 2012; 97
Amabile, Guerin, Leroyer, Mallat (CR8) 2005; 16
Shantsila (CR16) 2009; 23
Goichot, Grunebaum, Desprez, Vinzio (CR23) 2006; 32
Chironi, Simon, Hugel, Del Pino (CR46) 2006; 26
Langer, Chavakis (CR45) 2009; 13
Gregor, Hotamisligil (CR22) 2011; 29
Toth, Liebhardt, Steinig, Ditsch (CR14) 2008; 100
Mann (CR35) 2003; 124
Tan, Tayebjee, Lim, Lip (CR10) 2005; 22
Heijnen, Schiel, Fijnheer, Geuze, Sixma (CR25) 1999; 94
Key (CR33) 2010; 125
Morrissey (CR36) 2004; 79
Kumanyika, Jeffery, Morabia, Ritenbaugh (CR19) 2002; 26
Johnstone, Lobley, Horgan, Bremner (CR43) 2011; 106
Cohen, Gonzales, Davis-Gorman, Copeland, McDonagh (CR18) 2002; 107
Tan, Tayebjee, Macfadyen, Lip, Blann (CR11) 2005; 16
Shah, Bergeron, Dong, Lopez (CR3) 2008; 19
Madonna, De Caterina (CR42) 2011; 54
Boulanger, Amabile, Tedgui (CR15) 2006; 48
Murakami, Horigome, Tanaka, Nakata (CR29) 2007; 119
Lok, Nieuwland, Sturk, Hau (CR41) 2007; 18
VanWijk, VanBavel, Sturk, Nieuwland (CR37) 2003; 59
Ramacciotti, Blackburn, Hawley, Vandy (CR24) 2011; 17
(CR21) 1998; 6
Patil, Ghosh, Shetty (CR49) 2013; 98
Faure, Dou, Sabatier, Cerini (CR4) 2006; 4
Mobarrez, Antovic, Egberg, Hansson (CR6) 2010; 125
Stec, Silbershatz, Tofler, Matheney (CR31) 2000; 102
van der Zee, Biro, Ko, de Winter (CR40) 2006; 52
CR28
Gawaz, Langer, May (CR30) 2005; 115
Koga, Sugiyama, Kugiyama, Fukushima (CR9) 2006; 27
Eckel, Krauss (CR20) 1998; 97
Jy, Minagar, Jimenez, Sheremata (CR12) 2004; 9
Morel, Morel, Freyssinet, Toti (CR5) 2008; 19
Mallat, Benamer, Hugel, Benessiano (CR47) 2000; 101
Shet, Key, Hebbel (CR2) 2004; 2
Ashcroft, Sonneville, Yuana, Osanto (CR26) 2012; 14
R Lacroix (1000_CR50) 2012; 97
B Toth (1000_CR14) 2008; 100
Z Cohen (1000_CR18) 2002; 107
HF Langer (1000_CR45) 2009; 13
O Morel (1000_CR5) 2008; 19
MF Gregor (1000_CR22) 2011; 29
PM Zee van der (1000_CR40) 2006; 52
KT Tan (1000_CR10) 2005; 22
M Diamant (1000_CR34) 2002; 106
NS Key (1000_CR33) 2010; 125
G Chironi (1000_CR46) 2006; 26
AM Johnstone (1000_CR43) 2011; 106
R Madonna (1000_CR42) 2011; 54
M Gawaz (1000_CR30) 2005; 115
S Omoto (1000_CR48) 2002; 45
T Murakami (1000_CR29) 2007; 119
O Morel (1000_CR7) 2005; 98
S Kumanyika (1000_CR19) 2002; 26
AD Blann (1000_CR39) 2003; 24
MD Shah (1000_CR3) 2008; 19
R Patil (1000_CR49) 2013; 98
CA Lok (1000_CR41) 2007; 18
JJ Stec (1000_CR31) 2000; 102
V Evangelista (1000_CR38) 1999; 93
1000_CR32
MJ VanWijk (1000_CR37) 2003; 59
E Shantsila (1000_CR16) 2009; 23
E Ramacciotti (1000_CR24) 2011; 17
P Garcia Rodriguez (1000_CR1) 2010; 126
RB Arteaga (1000_CR44) 2006; 98
KG Mann (1000_CR35) 2003; 124
JH Morrissey (1000_CR36) 2004; 79
W Jy (1000_CR12) 2004; 9
AS Shet (1000_CR2) 2004; 2
1000_CR28
KH Jung (1000_CR17) 2009; 66
F Mobarrez (1000_CR6) 2010; 125
1000_CR26
KT Tan (1000_CR11) 2005; 16
V Faure (1000_CR4) 2006; 4
1000_CR21
H Koga (1000_CR9) 2006; 27
F Sabatier (1000_CR13) 2002; 51
HF Heijnen (1000_CR25) 1999; 94
Z Mallat (1000_CR47) 2000; 101
N Amabile (1000_CR8) 2005; 16
RP Wildman (1000_CR27) 2009; 12
RH Eckel (1000_CR20) 1998; 97
CM Boulanger (1000_CR15) 2006; 48
B Goichot (1000_CR23) 2006; 32
References_xml – volume: 9
  start-page: 3137
  year: 2004
  end-page: 3144
  ident: CR12
  article-title: Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis
  publication-title: Front Biosci
  doi: 10.2741/1466
– volume: 106
  start-page: 1
  issue: 2
  year: 2011
  end-page: 10
  ident: CR43
  article-title: Effects of a high-protein, low-carbohydrate v. high-protein, moderate-carbohydrate weight-loss diet on antioxidant status, endothelial markers and plasma indices of the cardiometabolic profile
  publication-title: Br J Nutr
  doi: 10.1017/S0007114511000092
– volume: 26
  start-page: 2775
  year: 2006
  end-page: 2780
  ident: CR46
  article-title: Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000249639.36915.04
– volume: 93
  start-page: 876
  year: 1999
  end-page: 885
  ident: CR38
  article-title: Platelet/polymorphonuclear leukocyte interaction: p-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule
  publication-title: Blood
– volume: 125
  start-page: S42
  issue: Suppl 1
  year: 2010
  end-page: S45
  ident: CR33
  article-title: Analysis of tissue factor positive microparticles
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2010.01.035
– volume: 98
  start-page: 70
  year: 2006
  end-page: 74
  ident: CR44
  article-title: Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.01.054
– volume: 2
  start-page: 1848
  year: 2004
  end-page: 1850
  ident: CR2
  article-title: Measuring circulating cell-derived microparticles
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2004.00941.x
– volume: 29
  start-page: 415
  year: 2011
  end-page: 445
  ident: CR22
  article-title: Inflammatory mechanisms in obesity
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-031210-101322
– volume: 22
  start-page: 1657
  year: 2005
  end-page: 1662
  ident: CR10
  article-title: Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2005.01707.x
– volume: 19
  start-page: 365
  year: 2008
  end-page: 372
  ident: CR3
  article-title: Flow cytometric measurement of microparticles: pitfalls and protocol modifications
  publication-title: Platelets
  doi: 10.1080/09537100802054107
– volume: 26
  start-page: 425
  year: 2002
  end-page: 436
  ident: CR19
  article-title: Obesity prevention: the case for action
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0801938
– volume: 98
  start-page: e69
  year: 2013
  ident: CR49
  article-title: Profibrinolytic microparticles are not adequately produced to compensate their prothrombotic effect
  publication-title: Haematologica
  doi: 10.3324/haematol.2013.083808
– volume: 97
  start-page: 1864
  year: 2012
  end-page: 1872
  ident: CR50
  article-title: Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis
  publication-title: Haematologica
  doi: 10.3324/haematol.2012.066167
– volume: 126
  start-page: 345
  year: 2010
  end-page: 349
  ident: CR1
  article-title: Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2010.07.006
– volume: 100
  start-page: 663
  year: 2008
  end-page: 669
  ident: CR14
  article-title: Platelet-derived microparticles and coagulation activation in breast cancer patients
  publication-title: Thromb Haemost
– volume: 17
  start-page: 425
  year: 2011
  end-page: 431
  ident: CR24
  article-title: Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis
  publication-title: Clin Appl Thromb Hemost
  doi: 10.1177/1076029611405032
– volume: 6
  start-page: 51S
  issue: Suppl 2
  year: 1998
  end-page: 209S
  ident: CR21
  article-title: National Institutes of Health
  publication-title: Obes Res
– volume: 52
  start-page: 657
  year: 2006
  end-page: 664
  ident: CR40
  article-title: P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2005.057414
– volume: 14
  start-page: 641
  issue: 4
  year: 2012
  end-page: 649
  ident: CR26
  article-title: Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics
  publication-title: Biomed Microdevices
– volume: 12
  start-page: 438
  year: 2009
  end-page: 443
  ident: CR27
  article-title: Healthy obesity
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e32832c6db7
– volume: 59
  start-page: 277
  year: 2003
  end-page: 287
  ident: CR37
  article-title: Microparticles in cardiovascular diseases
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(03)00367-5
– volume: 19
  start-page: 9
  year: 2008
  end-page: 23
  ident: CR5
  article-title: Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses
  publication-title: Platelets
  doi: 10.1080/09537100701817232
– ident: CR32
– volume: 18
  start-page: 68
  year: 2007
  end-page: 72
  ident: CR41
  article-title: Microparticle-associated P-selectin reflects platelet activation in preeclampsia
  publication-title: Platelets
  doi: 10.1080/09537100600864285
– volume: 97
  start-page: 2099
  year: 1998
  end-page: 2100
  ident: CR20
  article-title: American Heart Association call to action: obesity as a major risk factor for coronary heart disease
  publication-title: AHA Nutrition Committee.Circulation
  doi: 10.1161/01.CIR.97.21.2099
– volume: 27
  start-page: 817
  year: 2006
  end-page: 823
  ident: CR9
  article-title: Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehi746
– volume: 16
  start-page: 368
  year: 2005
  end-page: 371
  ident: CR11
  article-title: Elevated platelet microparticles in stable coronary artery disease are unrelated to disease severity or to indices of inflammation
  publication-title: Platelets
  doi: 10.1080/00207230500120401
– volume: 66
  start-page: 191
  year: 2009
  end-page: 199
  ident: CR17
  article-title: Circulating endothelial microparticles as a marker of cerebrovascular disease
  publication-title: Ann Neurol
  doi: 10.1002/ana.21681
– volume: 102
  start-page: 1634
  year: 2000
  end-page: 1638
  ident: CR31
  article-title: Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.14.1634
– volume: 23
  start-page: 359
  year: 2009
  end-page: 361
  ident: CR16
  article-title: Endothelial microparticles: a universal marker of vascular health?
  publication-title: J Hum Hypertens
  doi: 10.1038/jhh.2008.138
– volume: 124
  start-page: 4S
  year: 2003
  end-page: 10S
  ident: CR35
  article-title: Thrombin formation
  publication-title: Chest
  doi: 10.1378/chest.124.3_suppl.4S
– volume: 79
  start-page: 103
  year: 2004
  end-page: 108
  ident: CR36
  article-title: Tissue factor: a key molecule in hemostatic and nonhemostatic systems
  publication-title: Int J Hematol
  doi: 10.1532/IJH97.03167
– volume: 24
  start-page: 2166
  year: 2003
  end-page: 2179
  ident: CR39
  article-title: The adhesion molecule P-selectin and cardiovascular disease
  publication-title: Eur Heart J
  doi: 10.1016/j.ehj.2003.08.021
– volume: 101
  start-page: 841
  year: 2000
  end-page: 843
  ident: CR47
  article-title: Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.8.841
– volume: 51
  start-page: 2840
  year: 2002
  end-page: 2845
  ident: CR13
  article-title: Type 1 and type 2 diabetic patients display different patterns of cellular microparticles
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.9.2840
– volume: 115
  start-page: 3378
  year: 2005
  end-page: 3384
  ident: CR30
  article-title: Platelets in inflammation and atherogenesis
  publication-title: J Clin Invest
  doi: 10.1172/JCI27196
– volume: 119
  start-page: 45
  year: 2007
  end-page: 53
  ident: CR29
  article-title: Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2005.12.013
– volume: 48
  start-page: 180
  year: 2006
  end-page: 186
  ident: CR15
  article-title: Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000231507.00962.b5
– volume: 125
  start-page: e110
  year: 2010
  end-page: e116
  ident: CR6
  article-title: A multicolor flow cytometric assay for measurement of platelet-derived microparticles
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2009.10.006
– volume: 4
  start-page: 566
  year: 2006
  end-page: 573
  ident: CR4
  article-title: Elevation of circulating endothelial microparticles in patients with chronic renal failure
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2005.01780.x
– volume: 16
  start-page: 3381
  year: 2005
  end-page: 3388
  ident: CR8
  article-title: Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005050535
– volume: 45
  start-page: 550
  year: 2002
  end-page: 555
  ident: CR48
  article-title: Detection of monocyte-derived microparticles in patients with type II diabetes mellitus
  publication-title: Diabetologia
  doi: 10.1007/s00125-001-0772-7
– volume: 94
  start-page: 3791
  year: 1999
  end-page: 3799
  ident: CR25
  article-title: Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules
  publication-title: Blood
– volume: 98
  start-page: 226
  year: 2005
  end-page: 235
  ident: CR7
  article-title: Microparticles and cardiovascular disease
  publication-title: Arch Mal Coeur Vaiss
– volume: 32
  start-page: 82
  year: 2006
  end-page: 85
  ident: CR23
  article-title: Circulating procoagulant microparticles in obesity
  publication-title: Diabetes Metab
  doi: 10.1016/S1262-3636(07)70251-3
– volume: 106
  start-page: 2442
  year: 2002
  end-page: 2447
  ident: CR34
  article-title: Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000036596.59665.C6
– volume: 13
  start-page: 1211
  year: 2009
  end-page: 1220
  ident: CR45
  article-title: Leukocyte-endothelial interactions in inflammation
  publication-title: J Cell
– volume: 54
  start-page: 68
  year: 2011
  end-page: 74
  ident: CR42
  article-title: Cellular and molecular mechanisms of vascular injury in diabetes—part I: pathways of vascular disease in diabetes
  publication-title: Vascul Pharmacol
  doi: 10.1016/j.vph.2011.03.005
– volume: 107
  start-page: 217
  year: 2002
  end-page: 221
  ident: CR18
  article-title: Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation
  publication-title: Thromb Res
  doi: 10.1016/S0049-3848(02)00334-1
– ident: CR28
– volume: 59
  start-page: 277
  year: 2003
  ident: 1000_CR37
  publication-title: Cardiovasc Res
  doi: 10.1016/S0008-6363(03)00367-5
– volume: 16
  start-page: 368
  year: 2005
  ident: 1000_CR11
  publication-title: Platelets
  doi: 10.1080/00207230500120401
– volume: 23
  start-page: 359
  year: 2009
  ident: 1000_CR16
  publication-title: J Hum Hypertens
  doi: 10.1038/jhh.2008.138
– volume: 54
  start-page: 68
  year: 2011
  ident: 1000_CR42
  publication-title: Vascul Pharmacol
  doi: 10.1016/j.vph.2011.03.005
– volume: 16
  start-page: 3381
  year: 2005
  ident: 1000_CR8
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2005050535
– volume: 22
  start-page: 1657
  year: 2005
  ident: 1000_CR10
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2005.01707.x
– volume: 29
  start-page: 415
  year: 2011
  ident: 1000_CR22
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-031210-101322
– volume: 101
  start-page: 841
  year: 2000
  ident: 1000_CR47
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.8.841
– volume: 2
  start-page: 1848
  year: 2004
  ident: 1000_CR2
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2004.00941.x
– volume: 52
  start-page: 657
  year: 2006
  ident: 1000_CR40
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2005.057414
– volume: 126
  start-page: 345
  year: 2010
  ident: 1000_CR1
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2010.07.006
– ident: 1000_CR28
– volume: 115
  start-page: 3378
  year: 2005
  ident: 1000_CR30
  publication-title: J Clin Invest
  doi: 10.1172/JCI27196
– volume: 24
  start-page: 2166
  year: 2003
  ident: 1000_CR39
  publication-title: Eur Heart J
  doi: 10.1016/j.ehj.2003.08.021
– volume: 97
  start-page: 1864
  year: 2012
  ident: 1000_CR50
  publication-title: Haematologica
  doi: 10.3324/haematol.2012.066167
– volume: 9
  start-page: 3137
  year: 2004
  ident: 1000_CR12
  publication-title: Front Biosci
  doi: 10.2741/1466
– volume: 51
  start-page: 2840
  year: 2002
  ident: 1000_CR13
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.9.2840
– volume: 106
  start-page: 1
  issue: 2
  year: 2011
  ident: 1000_CR43
  publication-title: Br J Nutr
  doi: 10.1017/S0007114511000092
– volume: 48
  start-page: 180
  year: 2006
  ident: 1000_CR15
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000231507.00962.b5
– volume: 26
  start-page: 425
  year: 2002
  ident: 1000_CR19
  publication-title: Int J Obes Relat Metab Disord
  doi: 10.1038/sj.ijo.0801938
– volume: 106
  start-page: 2442
  year: 2002
  ident: 1000_CR34
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000036596.59665.C6
– volume: 98
  start-page: e69
  year: 2013
  ident: 1000_CR49
  publication-title: Haematologica
  doi: 10.3324/haematol.2013.083808
– volume: 19
  start-page: 365
  year: 2008
  ident: 1000_CR3
  publication-title: Platelets
  doi: 10.1080/09537100802054107
– ident: 1000_CR26
  doi: 10.1007/s10544-012-9642-y
– volume: 124
  start-page: 4S
  year: 2003
  ident: 1000_CR35
  publication-title: Chest
  doi: 10.1378/chest.124.3_suppl.4S
– volume: 98
  start-page: 226
  year: 2005
  ident: 1000_CR7
  publication-title: Arch Mal Coeur Vaiss
– volume: 79
  start-page: 103
  year: 2004
  ident: 1000_CR36
  publication-title: Int J Hematol
  doi: 10.1532/IJH97.03167
– volume: 102
  start-page: 1634
  year: 2000
  ident: 1000_CR31
  publication-title: Circulation
  doi: 10.1161/01.CIR.102.14.1634
– volume: 45
  start-page: 550
  year: 2002
  ident: 1000_CR48
  publication-title: Diabetologia
  doi: 10.1007/s00125-001-0772-7
– volume: 12
  start-page: 438
  year: 2009
  ident: 1000_CR27
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e32832c6db7
– volume: 18
  start-page: 68
  year: 2007
  ident: 1000_CR41
  publication-title: Platelets
  doi: 10.1080/09537100600864285
– volume: 98
  start-page: 70
  year: 2006
  ident: 1000_CR44
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2006.01.054
– volume: 94
  start-page: 3791
  year: 1999
  ident: 1000_CR25
  publication-title: Blood
  doi: 10.1182/blood.V94.11.3791
– volume: 32
  start-page: 82
  year: 2006
  ident: 1000_CR23
  publication-title: Diabetes Metab
  doi: 10.1016/S1262-3636(07)70251-3
– volume: 125
  start-page: S42
  issue: Suppl 1
  year: 2010
  ident: 1000_CR33
  publication-title: Thromb Res
– volume: 27
  start-page: 817
  year: 2006
  ident: 1000_CR9
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehi746
– volume: 97
  start-page: 2099
  year: 1998
  ident: 1000_CR20
  publication-title: AHA Nutrition Committee.Circulation
  doi: 10.1161/01.CIR.97.21.2099
– volume: 93
  start-page: 876
  year: 1999
  ident: 1000_CR38
  publication-title: Blood
  doi: 10.1182/blood.V93.3.876
– volume: 4
  start-page: 566
  year: 2006
  ident: 1000_CR4
  publication-title: J Thromb Haemost
  doi: 10.1111/j.1538-7836.2005.01780.x
– volume: 19
  start-page: 9
  year: 2008
  ident: 1000_CR5
  publication-title: Platelets
  doi: 10.1080/09537100701817232
– volume: 100
  start-page: 663
  year: 2008
  ident: 1000_CR14
  publication-title: Thromb Haemost
  doi: 10.1160/TH07-10-0602
– ident: 1000_CR32
– volume: 26
  start-page: 2775
  year: 2006
  ident: 1000_CR46
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/01.ATV.0000249639.36915.04
– volume: 125
  start-page: e110
  year: 2010
  ident: 1000_CR6
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2009.10.006
– volume: 107
  start-page: 217
  year: 2002
  ident: 1000_CR18
  publication-title: Thromb Res
  doi: 10.1016/S0049-3848(02)00334-1
– volume: 119
  start-page: 45
  year: 2007
  ident: 1000_CR29
  publication-title: Thromb Res
  doi: 10.1016/j.thromres.2005.12.013
– volume: 66
  start-page: 191
  year: 2009
  ident: 1000_CR17
  publication-title: Ann Neurol
  doi: 10.1002/ana.21681
– ident: 1000_CR21
– volume: 17
  start-page: 425
  year: 2011
  ident: 1000_CR24
  publication-title: Clin Appl Thromb Hemost
  doi: 10.1177/1076029611405032
– volume: 13
  start-page: 1211
  year: 2009
  ident: 1000_CR45
  publication-title: J Cell
SSID ssj0009902
Score 2.2916033
Snippet This study investigated the impact of either type 2 diabetes or obesity, separately or in combination, on the absolute amounts of microparticles (MP) and the...
SourceID proquest
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 455
SubjectTerms Adult
Aged
Atherosclerosis - blood
Atherosclerosis - etiology
Biomarkers - blood
Blood Platelets
Cardiology
Cell-Derived Microparticles - metabolism
Diabetes Mellitus, Type 2 - blood
Diabetic Angiopathies - blood
Female
Hematology
Humans
Leukocyte Count
Male
Medicine
Medicine & Public Health
Middle Aged
Obesity - blood
Platelet Activation
Risk Factors
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Na9wwEB3aFEIvpR9J43ZbptBTEhPbkmzlVErpEgopPTSwNyPJMgQ29iZel_bP9Ld2xpZ3E0Jzs7FsC89Iep55mgfwUQ7_PcLFTihOM4rT2BAyjWuZeobTOpW83_n8e352Ib8t1CIE3LpAq5zmxGGirlrHMfITXnilIrxdfFpdx6waxdnVIKHxGJ5w6TKmdBWLYlt0d-QcJgQBYkWOPWU1h61zNGUzU4iZWUkSZ3fXpXtg816idFh_5s_hWQCO-Hm09At45JuXsHseUuOv4O-PJcFGskJckVP98hVeMdduFVwDB1EINE2FXX9TG-fxalTG9eh_BzZsg6NeCgb2FjW1HKfpkMO1w8180PZr5NAtZjiFbo_xcqOnu17-wbbGdpQcQN6y1Hd7cDH_-vPLWRzEF8hqRUZ9lbkxSjmdptYyE9bSaLVpRYikUM5LYbQyWkprC2UI1ViRSkezgcuU1ZVKxD7sNG3jDwALWZ9qJ7TNDT1ValNnRhtdudqLXFgVQTJ9-tKFyuQskLEstzWV2VolWYvPkzKL4HBzy2osy_FQ49lkzzKM0K7c-lMEHzaXaWxxwsQ0vu2HNgTgtMh1BK9HP9i8LeNCYVmSR3A0Ocath_-vK28e7spbeEqATI6EyhnsrG96_45Az9q-Hzz7H-W3_X0
  priority: 102
  providerName: ProQuest
Title Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status
URI https://link.springer.com/article/10.1007/s11239-013-1000-2
https://www.ncbi.nlm.nih.gov/pubmed/24097206
https://www.proquest.com/docview/1515459607
https://www.proquest.com/docview/1516398368
Volume 37
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEB_0DsQX8due5zKCT2qhbZI297grux7KLYe4sD6VJE1B2GuP61bOf8a_1Zl-7Cqngk9paZKGzCT5JfPLDMAr2e17hAudUGxmFCehIWQaljL2DKd1LPm-89kyPV3JD2u1Hu5xNyPbfTRJdjP1_rIbTbLM7WEuVRSFNO8eKt66kxKvkune025PNIxo3Q8VafNoyvxTFb8vRjcQ5g3raLfoLO7DvQEt4rQX7wO45auHcOdssIc_gh_nG8KK1PVhQZr0zRd4wQS7y0EfsIsEgaYqsGmvSuM8XvThcD3664ECW2EfJAUHyhZltXw40yCf0XaF-aFut8jntZjgeF77Fr_uguhuN9-xLrHu4wwg31Nqm8ewWsw_vzsNh4gLJKosobbK1BilnI5ja5n-ammI2rggGJIp56UwWhktpbWZMgRlrIiloynAJcrqQkXiCRxUdeWfAWayPNFOaJsaqlVqUyZGG1240otUWBVANHZ97gZ35BwVY5PvHSmztHKSFr9HeRLA612Ry94Xx78yH4_yzIdh2eSM3qSiTVsWwMvdZxpQbCUxla_bLg-hNi1SHcDTXg92f0vYO1gSpQG8GRXjl8r_1pSj_8r9HO4SKJM9qfIYDrZXrX9BwGdrJ3A7W2cTOJwuZrMlp--_fJxTOpsvzz9NumHwE5y2_2U
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRcEG8CBYwEFyAi8SPrHhDi0WpLu6sKtVJvqe04EtI2WZoE6J_hJ_AbmcljF1TRW2-J4jhW5rPn88x4BuC5bPc9woVOKHIzis3QIDMNcxl7otM6lnTeeTpLJofy85E6WoPfw1kYCqsc1sR2oc5KRzbyN6R4pUK-PX63-BZS1Sjyrg4lNDpY7PqzH7hlq97ufEL5vuB8e-vg4yTsqwrgcMa8DjOZGKOU03FsLYV4WoShjTNUtWPlvBRGK6OltHasDKprK2LpEOaOK6szFQns9wqsS4FbmRGsf9ia7X9ZpfntohwjJB2hwqk0-FHbw3qoJCg2iWLBoijk_2rCc_T2nGu21XjbN-FGT1XZ-w5bt2DNF7fh6rR3xt-BX_tzJKoo9zBDGH_3GTuh6L5FD0bWlqFgpshY1Zzmxnl20tXi9cz_7ONvC9ZVaGF9vBg2tWQZqhgZiNuX6aJsakbGYsbZYCx-zb4uK_jW8zNW5qzsihwwOiTVVHfh8FIEcw9GRVn4B8DGMt_UTmibGOxVapNzo43OXO5FIqwKIBp-fer6XOhUkmOerrI4k7RSlBbdRykP4OXylUWXCOSixhuDPNN-TajSFYIDeLZ8jLOZXDSm8GXTtkHKqEWiA7jf4WD5NU6pyXiUBPBqAMZfnf9vKA8vHspTuDY5mO6lezuz3UdwHemg7MI5N2BUnzb-MVKu2j7pcc7g-LKn1h8NZTpJ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcKt4NtGAkuABREz8S91AhRFm1lFY9UGlvwXYcqdI2WZoE6J_hh_DrmMljF1TRW28breNYmW88k5nPMwAvZffdI1zohKI0o9gJDXqmYSFjT-60jiWddz46TvZP5aepmq7A7_EsDNEqxz2x26jzylGMfJsMr1Tob6fbxUCLONmbvJt_C6mDFGVax3YaPUQO_eUP_Hyrdw_2UNavOJ98_PJhPxw6DODSUt6EuUyMUcrpOLaW6J4WIWnjHM1uqpyXwmhltJTWpsqg6bYilg4h77iyOleRwHlvwe1UqJh0LJ2my4K_Pd8xQvcjVKhUY0a1O7aH5oJYSsQKi6KQ_2sTrzi6V5K0ne2b3IX1wWll73uU3YMVX96HtaMhLf8Afp3M0GVFBIQ5Avq7z9k58fzmAyxZ15CCmTJndXtRGOfZed-V1zP_c2Dilqzv1cIG5hgOtRQjqhmFirub6UfVNozCxoyzMWz8lp0tevk2s0tWFazq2x0wOi7V1g_h9EbE8ghWy6r0G8BSWexoJ7RNDM4qtSm40UbnrvAiEVYFEI2vPnNDVXRqzjHLlvWcSVoZSouuo4wH8Hpxy7wvCXLd4M1RntmwO9TZEssBvFj8jXpNyRpT-qrtxqDzqEWiA3jc42DxNE5FyniUBPBmBMZfk_9vKU-uX8pzWEOFyj4fHB8-hTvoF8qe17kJq81F67fQ92rssw7kDL7etFb9AV6DPRk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelet-derived+microparticle+count+and+surface+molecule+expression+differ+between+subjects+with+and+without+type+2+diabetes%2C+independently+of+obesity+status&rft.jtitle=Journal+of+thrombosis+and+thrombolysis&rft.au=Zhang%2C+Xuguang&rft.au=McGeoch%2C+Susan+C.&rft.au=Johnstone%2C+Alexandra+M.&rft.au=Holtrop%2C+Grietje&rft.date=2014-05-01&rft.issn=0929-5305&rft.eissn=1573-742X&rft.volume=37&rft.issue=4&rft.spage=455&rft.epage=463&rft_id=info:doi/10.1007%2Fs11239-013-1000-2&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s11239_013_1000_2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0929-5305&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0929-5305&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0929-5305&client=summon